SCHEMBL23987774

SCHEMBL23987774

CC(CCCN)CC1CC1

nearest known ligand 0.37

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CPB2 Q96IY4 5/20 0.34
▸ MAPT P10636 1/20 0.33
▸ SIGMAR1 Q99720 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13818683 0.93 CPB2 (0.39) CPB2MAPTSIGMAR1
SCHEMBL18812555 0.77 CPB2 (0.34) CPB2SIGMAR1
SCHEMBL4653068 0.77 MAPT (0.36) MAPT
SCHEMBL19245471 0.76 CPB2 (0.39) CPB2SIGMAR1
SCHEMBL1679114 0.75 — —
SCHEMBL1146663 0.74 LMNA (0.47) —
SCHEMBL17592565 0.74 NCF1 (0.35) MAPT
SCHEMBL17592566 0.74 NCF1 (0.35) MAPT
SCHEMBL17592628 0.74 NCF1 (0.35) MAPT
SCHEMBL23128664 0.74 OPRM1 (0.39) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3901151-A1 HALOGENATED-HETEROARYL AND OTHER HETEROCYCLIC KINASE INHIBITORS, AND USES THEREOF iOmx Therapeutics AG (DE) 2021-10-27 — — EP disclosed
Send feedback